MUSK and myasthenia gravis: Patients (n = 6, all female; mean age 44 ± 12 years, range 37–63; consistent with reported demographics of MuSK MG in refs. 34–36) with laboratory and clinically confirmed MuSK autoantibody–positive MG were selected for study.